Sepiapterin Pharmaceutical Composition Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmaceutical compositions of sepiapterin suffer from poor process efficiency, flow characteristics, and stability due to degradation in the presence of moisture, oxygen, and sunlight.
Innovation Solution
A solid pharmaceutical composition comprising sepiapterin, a water-soluble diluent, a water-insoluble diluent, a disintegrant, a suspending agent, a glidant, a sweetener, and a lubricant, which provides improved processability and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If sepiapterin is formulated as a simple powder composition, then manufacturing is simple, but stability is poor due to degradation from moisture, oxygen, and sunlight
Solution Approach 1:
The patent applies composite materials by formulating sepiapterin with multiple excipients including antioxidants (vitamin C, vitamin E), encapsulating agents (phytosphingosine), and stabilizers in a layered tablet structure. This composite formulation protects sepiapterin from degradation by moisture, oxygen, and sunlight while maintaining manufacturing feasibility through conventional tablet compression processes.
2Reliability
If sepiapterin is administered orally as synthetic BH4, then bioavailability is poor due to rapid oxidation and poor cell penetration, but if sepiapterin is used instead, then stability in plasma is improved
Solution Approach 1:
The patent uses phytosphingosine as an intermediary substance that facilitates the conversion of sepiapterin to BH4 within cells. This mediator enables efficient cellular uptake and enzymatic conversion, overcoming the poor bioavailability of oral synthetic BH4 while maintaining formulation manageability through a standardized tablet dosage form.
3Stability of the object's composition
If sepiapterin composition includes multiple excipients for stability, then stability is improved, but process efficiency and flow characteristics deteriorate
Solution Approach 1:
The patent segments the formulation into distinct functional layers within a multi-layer tablet structure, with sepiapterin in one layer and stabilizing excipients in separate layers. This segmentation improves manufacturing efficiency by allowing independent processing of each layer while maintaining overall stability, and enhances flow characteristics through optimized granulation of each segment.
Data Source
AI summary
This invention discloses a pharmaceutical composition of sepiapterin with improved processability, stability, and palatability.